Axsome Therapeutics Inc

Principal Statistical Programmer

United States

$148,000 – $190,000Compensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotechnology, CROIndustries

Position Overview

  • Location Type: Remote
  • Job Type: Full-Time
  • Salary: $148K - $190K

Iambic is seeking a Principal Statistical Programmer to join its Clinical Development team. This role is crucial for supporting statistical programming activities across all phases of clinical trials, from Phase I to regulatory submission. The ideal candidate will be a hands-on leader with extensive SAS programming expertise, a deep understanding of CDISC standards, regulatory requirements, and clinical trial processes. This position will also involve collaboration with data science and machine learning groups to integrate clinical data with existing AI infrastructure.

Key Responsibilities

  • Lead the design, development, validation, and maintenance of SAS programs for generating SDTM, ADaM, and TLFs (tables, listings, and figures).
  • Ensure adherence to CDISC standards (SDTM and ADaM), FDA/EMA regulatory guidelines, and internal SOPs.
  • Collaborate with Biostatisticians, Data Managers, and Clinical Operations teams to define programming requirements and timelines.
  • Conduct quality control and peer review of deliverables to ensure accuracy, consistency, and adherence to specifications.
  • Serve as the technical subject matter expert in statistical programming and mentor junior programmers.
  • Support the preparation of clinical study reports (CSRs), regulatory submission packages (e.g., eCTD, ISS/ISE), and responses to regulatory agencies.
  • Participate in the development and enhancement of departmental processes, templates, and tools to improve efficiency and quality.
  • Contribute to vendor oversight and provide technical leadership for outsourced programming activities.

Qualifications

Required:

  • Bachelor's or Master's degree in Computer Science, Statistics, Mathematics, Life Sciences, or a related field.
  • Minimum of 10 years of experience in statistical programming within the pharmaceutical, biotechnology, or CRO industry.
  • Proficiency in SAS/Base, SAS/Macro, SAS/SQL, and SAS/Graph.
  • Strong experience with CDISC standards (SDTM and ADaM) and familiarity with define.xml and Pinnacle 21.
  • Experience supporting regulatory submissions to FDA and/or EMA.
  • Excellent problem-solving skills, attention to detail, and the ability to work independently and collaboratively within a cross-functional team.

Preferred:

  • Familiarity with Python.
  • Experience in oncology clinical trials.
  • Exposure to cloud-based data systems or programming in a validated GxP environment.

About Iambic Therapeutics

Founded in 2020 and headquartered in San Diego, California, Iambic Therapeutics is leveraging a unique AI-driven drug-discovery platform to transform the therapeutics landscape. The company has assembled a world-class team of AI experts and experienced drug hunters with proven track records in developing clinically validated therapeutics. Iambic's platform is designed to deliver high-quality, differentiated therapeutics to the clinical stage rapidly and across various target classes and mechanisms of action. The company is advancing an internal pipeline of clinical assets to address critical unmet patient needs. Learn more at iambic.ai.

Mission & Core Values

Iambic's mission is to deliver better medicines through innovations in AI-based discovery technologies. The company fosters a culture that is significantly strengthened by the diversity of its people, including differences in background, culture, national origin, religion, sexual orientation, and life experiences. Iambic is committed to building an inclusive environment where a diverse group of talented individuals collaborate to discover therapeutics and create technologies.

Pay and Benefits

Iambic offers industry-leading competitive pay, company-paid healthcare, flexible spending accounts, voluntary life insurance, 401K matching, and uncapped vacation time.

Skills

SAS programming
CDISC standards
SDTM
ADaM
TLFs
Regulatory guidelines
Clinical trial processes
Quality control
Peer review
Clinical study reports
Regulatory submission
eCTD
ISS/ISE
Vendor oversight
Data science
Machine learning

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI